NCT00163618View on ClinicalTrials.gov

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

CompletedOBSERVATIONAL
Timeline

Start Date

June 30, 2005

Study Completion Date

July 31, 2006

Conditions
Encephalitis, Tick-borne
Interventions
BIOLOGICAL

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Trial Locations (4)

4040

Freistädter Strasse 290, Linz

4600

Grieskirchner Strasse 17, Wels

8570

Conrad-von-Hoetzendorf-Strasse, Voitsberg

9620

Bahnhofstraße 9, Hermagor

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00163618 - Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children | Biotech Hunter | Biotech Hunter